Cylene Pharmaceuticals Lands $12,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b5ef64f-72f9-45e5-adf2-cb32518f5bdd&Preview=1 -
Date
9/27/2010 -
Company Name
Cylene Pharmaceuticals -
Mailing Address
5820 Nancy Ridge Drive San Diego, CA 92121 -
Company Description
Cylene Pharmaceuticals, Inc. is a privately held pharmaceutical company dedicated to the discovery, development and commercialization of first-in-class small molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. -
Website
http://www.cylenepharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used to expand the human clinical trials program for CX-4945, including the Phase I trial in patients with multiple myeloma and a series of randomized Phase II trials. -
M&A Terms
-
Venture Investor
Sanderling Ventures -
Venture Investor
HBM Bioventures -
Venture Investor
Novartis BioVenture Fund -
Venture Investor
Bioventures Investors -
Venture Investor
Lilly Ventures -
Venture Investor
Mitsui & Co Ltd -
Venture Investor
Morningside Group
